Breaking News

Immutep Ltd ADR (IMMP)

	Symbol	Exchange	Currency
	IMMP	NASDAQ	USD	Real-time
	IMM	Sydney	AUD	Delayed

Add to/Remove from a Portfolio Add to Watchlist

1.700 -0.070 -3.95%

18:47:27 - Real-time Cboe. Currency in USD

Type: Equity

Market: United States

Volume: 69,060
Bid/Ask: 0.000 / 0.000
Day's Range: 1.670 - 1.750

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Immutep Ltd ADR Company Profile

Get an in-depth profile of Immutep Ltd ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ADR

Immutep Limited, a late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alpha (efti or IMP321), a soluble LAG-3lg fusion based, which is in clinical development for the treatment of different types of cancers. The company’s product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. In addition, it develops INSIGHT-003, which is in phase I to treat 1L NSCLC and solid tumors; INSIGHT-005, which is in phase I to treat metastatic urothelial cancer; IMP761, which is in preclinical trial to treat autoimmune disease; and IMP731 and IMP701 which is in clinical development. Further, the company develops LAG525, which is in phase II clinical trial to treat solid tumors and blood cancer, triple negative breast cancer, and melanoma; and in phase I to treat triple negative breast cancer. Immutep has collaboration with Merck & Co., Inc., GlaxoSmithKline, EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

Contact Information

Address Australia Square Level 32
264 George Street Sydney, 2000
Australia

Phone 61 2 8315 7003

Fax 61 2 8569 1880

Web www.immutep.com

Top Executives

Name	Age	Since	Title
Marc Voigt	50	2011	CEO, MD, CFO, Chief Business Officer & Executive Director
Frederic Triebel	68	2014	Chief Scientific Officer & Executive Director
Pete A. Meyers	53	2014	Independent Non-Executive Deputy Chairman
Elisabeth Boyce	-	2023	Non-Executive Director
Leisha A. Emens	-	2022	Member of Clinical Advisory Board
Scott Joseph Antonia	-	2022	Member of Clinical Advisory Board
Russell J. Howard	74	2013	Independent Non-Executive Chairman
Martine J. Piccart	-	2017	Chairman of Clinical Advisory Board
Salah-Eddin Al-Batran	-	2017	Member of Clinical Advisory Board
Martin Forster	-	2022	Member of Clinical Advisory Board
Hans Wildiers	-	2022	Member of Clinical Advisory Board

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

IMMP Comments

Write your thoughts about Immutep Ltd ADR

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,152.99	+13.06	+0.25%
NSE All Share	141,439.75	+435.61	+0.31%
US 30	45,380.9	-250.8	-0.55%
US 500	6,460.4	-6.5	-0.10%
FTSE 100	9,321.40	+12.20	+0.13%
DAX	24,261.59	-101.50	-0.42%
South Africa Top 40	95,329.31	+262.45	+0.28%

Brent Oil	68.33	+1.11	+1.65%
Crude Oil WTI	64.94	+1.28	+2.01%
Gold	3,417.05	-1.45	-0.04%
Silver	38.693	-0.361	-0.93%
Copper	4.5475	+0.0200	+0.44%
London Cocoa	5,332.00	-26.00	-0.49%
London Wheat	168.05	-1.25	-0.74%

Nigeria 10Y	15.681	0.000	0.00%
Nigeria 2Y	16.836	+0.002	+0.01%
U.K. 10Y	4.6900	-0.0380	-0.80%
Germany 10Y	2.7423	-0.0157	-0.57%
U.S. 10Y	4.269	+0.009	+0.21%
U.S. 5Y	3.778	+0.021	+0.56%
U.S. 2Y	3.724	+0.035	+0.95%

Fidelitybk	20.850	-0.050	-0.24%
Zenith Bank	70.00	0.00	0.00%
UBA	47.95	0.00	0.00%
First HoldCo	32.50	0.00	0.00%
Guaranty Trust Holding	96.05	+2.05	+2.18%
Sterling Bank	7.700	+0.150	+1.99%
Dangote Cement	520.00	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
IMMP	1.700	-0.070	-3.95%
2880	28.00	-0.15	-0.53%
WACOAL	17.50	-0.50	-2.78%
7389	3,005.00	+37.00	+1.25%
NATU	384.50	+17.30	+4.71%
300969	90.94	-0.89	-0.97%
Birla Sun Life Ba.	23.440	-0.180	-0.76%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	10.900	-0.91%	105.13M
Guaranty Trust Holding	96.05	+2.18%	25.00M
Access Holdings	27.45	+1.67%	15.69M
UBA	47.95	0.00%	14.23M
Zenith Bank	70.00	0.00%	10.18M
Aradel Holdings	510.00	-1.73%	2.66M
Julius Berger	146.10	+9.93%	2.15M

Name	Last	Chg. %	Vol.
Julius Berger	146.10	+9.93%	2.15M
Cutix	3.900	+9.86%	2.13M
Regal Insurance	1.47	+9.70%	15.85M
Veritas Kapital	2.17	+9.60%	59.57M
McNichols	3.50	+9.38%	677.72K
Nem	28.950	+8.83%	529.28K
Universal Insurance PLC	1.32	+8.20%	34.40M

Name	Last	Chg. %	Vol.
University Pre	5.540	-12.06%	681.46K
Cadbury Nig	57.85	-9.61%	660.41K
Abbey Mortgage Bank	6.55	-8.39%	254.88K
Daarcomm	1.12	-7.44%	3.04M
Austin Laz	2.71	-6.55%	2.59M
Mecure Industries	19.50	-6.02%	421.01K
Tantalizers	2.50	-5.66%	4.86M